is mounjaro better than tirzepatide vs. Ozempic: Comparing Diabetes Treatments & Weight Loss Benefits Are Tirzepatide and Mounjaro the

and D.M

New Trial Results STEP-HFpEF DM published in NEJM today Semaglutide improved heart failure symptoms and physical limitations in patients with obesity, HFpEF and Type 2 Diabetes 6.4% weight over placebo CRP 6 min walk distance These results are consistent with findings of a prior trial of semaglutide in HFpEF and obesity without type 2 diabetes

Tirzepatide: Tirzepatide targets both the GIP and GLP-1 receptors, providing a synergistic effect that enhances insulin secretion, slows gastric emptying, and reduces appetite

A.PihlajamkiJ.SoininenH.HiltunenM

The report itselfnot a marketing badgeshould be treated as the source record

Is tirzepatide safe to use long-term